CS

Chandra Sekhar Tumuluru

Active Director Director DIN 07212178
DIN 07212178 First appointment Mar 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 38 historical roles
Total affiliations 42 Since Mar 2015
Shareholding value •••• Premium profile

About Chandra Sekhar Tumuluru

Data last updated:

Chandra Sekhar Tumuluru is a Director at Cirex Pharmaceuticals Private Limited (since 2015), Director at Sygmos Lab Private Limited (since 2015) and Designated Partner at Krishn Global Ifsc Llp (since 2024), and holds 1 more current directorship. The companies operate in Pharma, Chemicals and Real Estate and Construction. The 2 current companies with reported revenue have a combined latest revenue of ₹37.00 Cr; the largest is Cirex Pharmaceuticals Private Limited at ₹27.51 Cr (FY 2025). Earlier, Chandra Sekhar Tumuluru was a Director at Selmar Lab Private Limited (2018–2025) and Director at Asphar Research Labs Private Limited (2017–2025) and 36 more.

DIN 07212178
Primary Designation Director
Industry Pharma
First Appointment 31 Mar 2015
Oldest Company Age 35 yrs
Largest company Cirex Pharmaceuticals Private Limited · ₹27.51 Cr (FY 2025)
Combined revenue ₹37.00 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Jul 20151990₹27.51 Cr (FY 2025)Active
Sygmos Lab Private Limited U24232AP2015PTC105869
Director10 Aug 20152015₹9.49 Cr (FY 2025)Active
Designated Partner12 Dec 20242024Active
Designated Partner27 Jul 20232020Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Selmar Lab Private Limited U24100TG2013PTC089489
Director31 Dec 20182013₹269 Cr (FY 2024)Active
Asphar Research Labs Private Limited U24304TG2017PTC117269
Director01 Sep 20172017₹7.57 Cr (FY 2025)Active
Director08 Oct 20152007₹18.81 Cr (FY 2025)Active
Director18 Feb 20161984Under Process Of Striking Off
Director25 Feb 20212006Under Process Of Striking Off
Yatnam Lab Limited U24304TG2017PLC115152
Director10 Feb 20172017₹15,000 (FY 2025)Active
Director30 Jan 20252023₹1,053 Cr (FY 2025)Active
Anaika Infracon Private Limited U68200TS2023PTC176807
Director09 Nov 20232023Active
Hoster Labs Private Limited U24230TG2020PTC141547
Director09 Jul 20202020₹74.69 Cr (FY 2024)Amalgamated
Additional Director09 Jul 20152004Strike Off
Strivo Pharma Private Limited U24302TG2016PTC109188
Director25 Apr 20162016Amalgamated
Director22 Aug 20152008₹80,000 (FY 2019)Amalgamated
Director25 Feb 20212006Amalgamated
Director22 Aug 20152008₹80,000 (FY 2019)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Chandra Sekhar Tumuluru

Directorship timeline

Open interactive timeline →
Cirex Pharmaceuticals Private Limited
Hoster Labs Private Limited
Sygmos Lab Private Limited
Invagen Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Chandra Sekhar Tumuluru

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandra Sekhar Tumuluru

Chandra Sekhar Tumuluru currently holds 4 directorships: Cirex Pharmaceuticals Private Limited (Director, since 14 Jul 2015, revenue ₹27.51 Cr (FY 2025)); Sygmos Lab Private Limited (Director, since 10 Aug 2015, revenue ₹9.49 Cr (FY 2025)); Krishn Global Ifsc Llp (Designated Partner, since 12 Dec 2024); Eashan Infraventures Llp (Designated Partner, since 27 Jul 2023).

Chandra Sekhar Tumuluru was first appointed on 31 Mar 2015 as Director at Honour Infra Estates Limited. The most recent appointment on record is 31 Mar 2025 at Hetero Plasma Sciences Private Limited.

The 2 current companies of Chandra Sekhar Tumuluru that report revenue have a combined latest revenue of ₹37.00 Cr: Cirex Pharmaceuticals Private Limited ₹27.51 Cr (FY 2025); Sygmos Lab Private Limited ₹9.49 Cr (FY 2025).

Chandra Sekhar Tumuluru held 38 earlier board appointments: Selmar Lab Private Limited (Director, 31 Dec 2018 to 23 Oct 2025); Asphar Research Labs Private Limited (Director, 01 Sep 2017 to 22 Oct 2025); Sri Sai Ashirwaad Enterprises Private Limited (Director, 08 Oct 2015 to 06 Oct 2025); Svs Drugs And Pharmaceuticals Pvt Ltd (Director, 18 Feb 2016 to 06 Oct 2025); Veer West Realty India Private Limited (Director, 25 Feb 2021 to 03 Oct 2025); and 33 more.

The current boards of Chandra Sekhar Tumuluru's companies include Navin Kumar Reddy Puchakayala (Cirex Pharmaceuticals Private Limited), Kavitha Kumari Maddika (Sygmos Lab Private Limited), Lokesh Chandra Dasari (Sygmos Lab Private Limited), Surendra Reddy Chintakunta (Sygmos Lab Private Limited), Anvida Bandi (Krishn Global Ifsc Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available